Cannabinoids and Chronic Liver Diseases

Cannabinoids and Chronic Liver Diseases

Nonalcoholic fatty liver disease (NAFLD), alcohol-induced liver disease (ALD), and viral hepatitis are the main causes of morbidity and mortality related to chronic liver diseases (CLDs) worldwide. New therapeutic approaches to prevent or reverse these liver disorders are thus emerging. Although the...

Full description

Bibliographic Details
Main Authors: Ralph-Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, Mohammad-Ali Jenabian, Cecilia T. Costiniuk
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:International Journal of Molecular Sciences
Subjects:
endocannabinoid system
cannabinoids
cannabidiol (CBD)
tetrahydrocannabinol (THC)
insulin resistance
chronic liver diseases
Online Access:https://www.mdpi.com/1422-0067/23/16/9423

Internet

https://www.mdpi.com/1422-0067/23/16/9423

Similar Items